United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Concord Medical Services Holdings Ltd? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | 13.82% | - | -60.33% | -64.19% | -64.11% | -63.36% |
|---|---|---|---|---|---|---|
| ROA | -4.76% | -3.14% | -3.02% | -3.21% | -3.21% | -3.17% |
| Gross Margin | -20.62% | 15% | 15% | 15% | 15% | 15.27% |
| Net Margin | -80.28% | -49.87% | -47.65% | -49.04% | -49.17% | -48.72% |
| Total Assets | $921,512.00K | $993,094.94K | $1,070,427.70K | $1,153,972.58K | $1,244,229.09K | $1,341,605.81K |
| Net Income | -$42,228.00K | -$30,051.71K | -$31,122.18K | -$35,694.26K | -$38,435.90K | -$40,957.25K |